M. KARACA Et Al. , "Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy," Medical Science Monitor , vol.30, 2024
KARACA, M. Et Al. 2024. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy. Medical Science Monitor , vol.30 .
KARACA, M., Salim, E., Alemdar, M. S., Karaca, Ö. D., & Arıcı, M. Ö., (2024). Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy. Medical Science Monitor , vol.30.
KARACA, MUSTAFA Et Al. "Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy," Medical Science Monitor , vol.30, 2024
KARACA, MUSTAFA Et Al. "Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy." Medical Science Monitor , vol.30, 2024
KARACA, M. Et Al. (2024) . "Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy." Medical Science Monitor , vol.30.
@article{article, author={MUSTAFA KARACA Et Al. }, title={Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy}, journal={Medical Science Monitor}, year=2024}